CSIMarket Company Name, Ticker, Competitors, else..


Johnson and Johnson  (JNJ)
Other Ticker:  
 

Johnson and Johnson

JNJ's Fundamental analysis



Looking into Johnson And Johnson growth rates, revenue grew by 5.63 % in I. Quarter 2023 from the same quarter a year ago. Ranking at No. 830

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -8.24 %

Johnson And Johnson faced net loss in contrast to the net income a year ago in I. Quarter 2023

• More on JNJ's Growth


Johnson And Johnson
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Company is currently trading with Price to Cash flow multiple of 32.7 in trailing twelve-month period.
Company
33.55
PE TTM   
Industry
0.01
PE TTM    
Company's Price to Sales ratio is at 4.34.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 6.2.


• More on JNJ's Valuation
 
 Total Debt (Millions $) 52,907
 Dividend TTM ($) 4.47 $
 Dividend Yield TTM (%) 2.73 %
 Revenue/Employee (TTM) $ 679,344
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 5.97
 Tangible Book Value (Per Share $) -8.50

Johnson And Johnson
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Company is currently trading with Price to Cash flow multiple of 32.7 in trailing twelve-month period.
Company
33.55
PE TTM   
Industry
0.01
PE TTM    
Company's Price to Sales ratio is at 4.34.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 6.2.

Johnson And Johnson Price to Book Ratio is at 5.89 higher than Indusry Avg. of -1028.47, and lower than S&P 500 Avg. of 1405.53

• More on JNJ's Valuation

•  Market Capitalization (Millions $) 417,557
•  Shares Outstanding (Millions) 2,606
•  Employees 141,700
•  Revenues (TTM) (Millions $) 96,263
•  Net Income (TTM) (Millions $) 12,724
•  Cash Flow (TTM) (Millions $) 12,768
•  Capital Exp. (TTM) (Millions $) -4,265
•  Total Debt (Millions $) 52,907
•  Dividend TTM ($) 4.47 $
•  Dividend Yield TTM (%) 2.73 %
•  Revenue/Employee (TTM) $ 679,344
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) 5.97
•  Tangible Book Value (Per Share $) -8.50

•  Market Capitalization (Millions $) 417,557
•  Shares Outstanding (Millions) 2,606
•  Employees 141,700
•  Revenues (TTM) (Millions $) 96,263
•  Net Income (TTM) (Millions $) 12,724
•  Cash Flow (TTM) (Millions $) 12,768
•  Capital Exp. (TTM) (Millions $) -4,265


    JNJ's Profitability Comparisons
Johnson And Johnson faced margin deterioraten, primarily through cost pressure. Operating Margin fell in I. Quarter 2023 to 40.55 % from 84.09 % in IV. Quarter.




Profitability by Segment
Total Pharmaceutical 57.17 %
Med. Dev. & Diag. 47.39 %
Total Consumer 38.9 %



  Ratio
•   Capital Ratio (MRQ) 1.41
•  Total Debt to Equity (MRQ) 0.75
•  Tangible Leverage Ratio (MRQ) -
•  Asset Turnover Ratio (TTM) 0.52
•  Inventory Turnover Ratio (TTM) 2.63



Johnson And Johnson faced margin deterioraten, primarily through cost pressure. Operating Margin fell in I. Quarter 2023 to 40.55 % from 84.09 % in IV. Quarter.



• More on JNJ's Key Ratios





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071